Stockholm-3模型更新:算法优化、生物标志物贡献与反射检测潜力
Stockholm-3研究在50-69岁男性中评估更新版S3M与PSA检出Gleason≥7前列腺癌的性能,更新后S3M的AUC为0.75 vs 既往0.74;对PSA≥3ng/ml男性作为反射检测,在相同敏感性下活检数较单用PSA减少34%。
要点
- 更新版S3M较既往版本AUC略有提高(0.75 vs 0.74)。
- PSA≥3ng/ml男性用S3M反射检测,同等敏感性下活检数减少34%。
- S3M作为PSA筛查后的二次检测可减少不必要活检。
核心结论
- 将S3M作为PSA≥3ng/ml男性的反射检测,可在保持同等敏感性的前提下减少活检数量,缓解PSA筛查中过多不必要活检的问题。
研究设计与样本
- 共5073名男性因PSA升高(≥3ng/ml)接受活检。
主要发现
- 更新版S3M较既往发表结果的AUC略有提高(0.75 vs 0.74)。
- 对PSA≥3ng/ml男性作为反射检测,S3M在同等敏感性下较单用PSA减少34%的活检数。
关键数值与推荐
- 更新S3M时移除完整PSA、纳入HOXB13,并在Stockholm-3训练与验证队列中拟合模型。
- 比较S3M与PSA时固定高危癌症检出敏感性,以各检测达到该敏感性所需活检数评估性能。
临床怎么用
- 对PSA≥3ng/ml的50-69岁男性,可考虑将更新版S3M作为反射检测以在同等敏感性下减少活检。
局限性
- 原文述局限性为人群种族同质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It has been shown that the Stockholm-3 model (S3M) outperforms prostate-specific antigen (PSA) as a screening tool for prostate cancer. OBJECTIVE: To update the S3M, to give a detailed account of the value of each predictor in the S3M, and to evaluate the S3M as a reflex test for men with PSA ≥3ng/ml. DESIGN, SETTING, AND PARTICIPANTS: During 2012-2015, the Stockholm-3 study evaluated the S3M relative to PSA as tests for Gleason score ≥7 prostate cancers among men aged 50-69 yr. The participants (n=59 159) underwent both tests, and biopsy was recommended if at least one was positive. A total of 5073 men had a biopsy because of elevated PSA (≥3ng/ml). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Logistic regression was used to update the S3M: intact PSA was removed, HOXB13 was included, and the model was fitted to data from the Stockholm-3 training and validation cohorts. To compare S3M with PSA, we fixed the sensitivity for detection of high-grade cancer and evaluated the performance as the number of biopsies needed to achieve that sensitivity for each test. RESULTS AND LIMITATIONS: The updated S3M slightly improved the area under the receiver operating characteristic curve compared to previously published results (0.75 vs 0.74). When used as a reflex test for men with PSA ≥3ng/ml, S3M reduced the number of biopsies needed by 34% compared to the use of PSA alone, with equal sensitivity. A limitation is the ethnically homogeneous population. CONCLUSIONS: A major problem with PSA screening-too many unnecessary biopsies-can be mitigated if S3M is used as a reflex test. PATIENT SUMMARY: To find aggressive prostate cancer with the minimum number of negative biopsies and detection of clinically insignificant cancers, we evaluated the use of a personalized diagnostic prediction model as a second test for men with a positive prostate-specific antigen (PSA) test. We found that this two-step approach could reduce prostate biopsies by a third compared to using PSA alone.
引用
- Ström P, Nordström T, Aly M, et al. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. 2018. PMID: 29331214. doi:10.1016/j.eururo.2017.12.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。